SGLT2 Inhibitors Improve Outcomes in Patients With Diabetes Plus Kidney Disease
Benefits include lower risk for dialysis, hospitalization for myocardial infarction, heart failure, acute kidney injury, and diabetic ketoacidosis
People With Opioid Use Disorder Less Likely to Receive Palliative Care
Difference did not persist after exclusion of people who died suddenly
Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas
Overall response rate was 25.0 percent in phase 2 study involving 17 patients
Patient Gets First-Ever Pig Kidney Transplant Plus Heart Pump
Leukocyte Glucose Index, Arteriovenous Fistula Failure Linked in ESKD
Risk for AVF failure significantly higher for patients with higher baseline LGI, independent of age, sex, CV risk factors
Hospital Mortality Lower for Patients Treated by Female Physicians
Benefit of receiving treatment from female physicians larger for female than male patients
Risk Prediction Model Accurate for Chronic Kidney Disease
KDpredict more accurate than kidney failure risk equation for prediction of kidney failure risk
Improvement Seen in Survival With Adjuvant Pembrolizumab in Kidney Cancer
Disease-free survival benefit was consistent with that seen in previous analyses; improvement in overall survival also seen
Bilateral Wilms Tumors That Grow During Chemo Mostly Stromal-Predominant
Patients with stromal-predominant tumors had the youngest age at diagnosis compared with other histologic subtypes
EHR-Based Algorithm Does Not Cut Hospitalization in Kidney Dysfunction Triad
No reduction seen in hospitalization at one year with use of EHR-based algorithm and practice facilitators in primary care
